Pfizer-BioNTech
More News
-
UAE, Bahrain make Pfizer/BioNTech shot available to those who got Sinopharm vaccine
Bahrain is currently fighting its biggest wave of infections
-
Pfizer vaccine effective in those with chronic illnesses
Pfizer/BioNTech vaccine is effective at preventing severe disease in people who have diabetes and heart condition
-
Johnson & Johnson jab may cause unusual blood clotting
According to the EU agency, over 7 million people received the product of the Johnson & Johnson pharma company
-
Vaccinating adults appears to protect children around them
New data from Israel suggests that the vaccination of adults also protects unvaccinated people living around them
-
Immune response may be linked to AstraZeneca vaccine clot issue
Four previously healthy individuals who got the AstraZeneca shot and developed life-threatening clots
-
Pfizer, BioNTech launch Covid-19 vaccine trial in kids under 12
First volunteers in early-stage trial were given their first injections on Wednesday, says Pfizer spokesperson
-
Pregnant women infected by Covid-19 at higher rate, reveals study
Pregnant women in non-white racial/ethnic groups were particularly vulnerable to coronavirus
-
South African virus variant may resist antibody drugs
Covid-19 vaccine from Pfizer and BioNTech SE is likely to protect against the more infectious variant of the virus
-
European medicines regulator approves Pfizer-BioNTech Covid-19 vaccine
EU countries including Germany, Austria and Italy say they plan to start vaccinations from Dec 27
-
Some vaccine doses kept too cold, Pfizer having manufacturing issues, US officials say
Officials did not outline what the specific manufacturing challenges were
-
Explainer: What do the UK allergic reaction cases mean for Pfizer's Covid-19 vaccine
UK officials said there have been two reports of anaphylaxis and one of a possible allergic reaction
-
India could authorise Covid-19 vaccines in weeks, 300 million on priority list
Pfizer Inc sought emergency-use authorisation in India, followed by Astra Zeneca’s Covishield vaccine
-
Factbox: Development of Pfizer-BioNTech coronavirus vaccine
The price tag amounts to $39 for what is likely to be a two-dose course of treatment









